vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Zeta Global Holdings Corp. (ZETA). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $394.6M, roughly 1.3× Zeta Global Holdings Corp.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 1.7%, a 5.2% gap on every dollar of revenue. On growth, Zeta Global Holdings Corp. posted the faster year-over-year revenue change (25.4% vs -1.7%). Over the past eight quarters, Zeta Global Holdings Corp.'s revenue compounded faster (42.3% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Zeta Global Holdings Corp. is an American marketing technology company which was founded in 2007. Zeta offers companies a suite of multichannel marketing tools focused on creating, maintaining, and monetizing customer relationships. The company went public on the New York Stock Exchange on June 10, 2021, at a US$1.7 billion valuation.
MD vs ZETA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $394.6M |
| Net Profit | $33.7M | $6.5M |
| Gross Margin | — | 59.5% |
| Operating Margin | 9.9% | 4.5% |
| Net Margin | 6.8% | 1.7% |
| Revenue YoY | -1.7% | 25.4% |
| Net Profit YoY | 10.5% | -57.1% |
| EPS (diluted) | $0.40 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $394.6M | ||
| Q3 25 | $492.9M | $337.2M | ||
| Q2 25 | $468.8M | $308.4M | ||
| Q1 25 | $458.4M | $264.4M | ||
| Q4 24 | $502.4M | $314.7M | ||
| Q3 24 | $511.2M | $268.3M | ||
| Q2 24 | $504.3M | $227.8M | ||
| Q1 24 | $495.1M | $194.9M |
| Q4 25 | $33.7M | $6.5M | ||
| Q3 25 | $71.7M | $-3.6M | ||
| Q2 25 | $39.3M | $-12.8M | ||
| Q1 25 | $20.7M | $-21.6M | ||
| Q4 24 | $30.5M | $15.2M | ||
| Q3 24 | $19.4M | $-17.4M | ||
| Q2 24 | $-153.0M | $-28.1M | ||
| Q1 24 | $4.0M | $-39.6M |
| Q4 25 | — | 59.5% | ||
| Q3 25 | — | 60.5% | ||
| Q2 25 | — | 62.1% | ||
| Q1 25 | — | 60.9% | ||
| Q4 24 | — | 60.0% | ||
| Q3 24 | — | 60.6% | ||
| Q2 24 | — | 60.0% | ||
| Q1 24 | — | 60.6% |
| Q4 25 | 9.9% | 4.5% | ||
| Q3 25 | 13.8% | 2.6% | ||
| Q2 25 | 12.8% | -1.7% | ||
| Q1 25 | 7.0% | -6.1% | ||
| Q4 24 | 7.8% | 2.2% | ||
| Q3 24 | 6.6% | -4.6% | ||
| Q2 24 | -31.3% | -11.7% | ||
| Q1 24 | 3.2% | -18.4% |
| Q4 25 | 6.8% | 1.7% | ||
| Q3 25 | 14.5% | -1.1% | ||
| Q2 25 | 8.4% | -4.2% | ||
| Q1 25 | 4.5% | -8.2% | ||
| Q4 24 | 6.1% | 4.8% | ||
| Q3 24 | 3.8% | -6.5% | ||
| Q2 24 | -30.3% | -12.3% | ||
| Q1 24 | 0.8% | -20.3% |
| Q4 25 | $0.40 | $0.04 | ||
| Q3 25 | $0.84 | $-0.02 | ||
| Q2 25 | $0.46 | $-0.06 | ||
| Q1 25 | $0.24 | $-0.10 | ||
| Q4 24 | $0.37 | $0.10 | ||
| Q3 24 | $0.23 | $-0.09 | ||
| Q2 24 | $-1.84 | $-0.16 | ||
| Q1 24 | $0.05 | $-0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $319.8M |
| Total DebtLower is stronger | $570.5M | $197.1M |
| Stockholders' EquityBook value | $865.9M | $804.6M |
| Total Assets | $2.2B | $1.5B |
| Debt / EquityLower = less leverage | 0.66× | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $319.8M | ||
| Q3 25 | $340.1M | $385.2M | ||
| Q2 25 | $224.7M | $365.3M | ||
| Q1 25 | $99.0M | $364.4M | ||
| Q4 24 | $229.9M | $366.2M | ||
| Q3 24 | $103.8M | $418.5M | ||
| Q2 24 | $19.4M | $154.7M | ||
| Q1 24 | $8.0M | $141.6M |
| Q4 25 | $570.5M | $197.1M | ||
| Q3 25 | $577.2M | $196.9M | ||
| Q2 25 | $583.9M | $196.7M | ||
| Q1 25 | $590.5M | $196.5M | ||
| Q4 24 | $597.1M | $196.3M | ||
| Q3 24 | — | $196.1M | ||
| Q2 24 | — | $184.4M | ||
| Q1 24 | — | $184.2M |
| Q4 25 | $865.9M | $804.6M | ||
| Q3 25 | $890.7M | $689.2M | ||
| Q2 25 | $833.8M | $673.3M | ||
| Q1 25 | $789.2M | $676.6M | ||
| Q4 24 | $764.9M | $676.8M | ||
| Q3 24 | $732.5M | $474.9M | ||
| Q2 24 | $706.5M | $217.0M | ||
| Q1 24 | $856.2M | $191.6M |
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.2B | $1.2B | ||
| Q2 25 | $2.1B | $1.1B | ||
| Q1 25 | $2.0B | $1.1B | ||
| Q4 24 | $2.2B | $1.1B | ||
| Q3 24 | $2.1B | $869.1M | ||
| Q2 24 | $2.0B | $583.9M | ||
| Q1 24 | $2.2B | $550.3M |
| Q4 25 | 0.66× | 0.24× | ||
| Q3 25 | 0.65× | 0.29× | ||
| Q2 25 | 0.70× | 0.29× | ||
| Q1 25 | 0.75× | 0.29× | ||
| Q4 24 | 0.78× | 0.29× | ||
| Q3 24 | — | 0.41× | ||
| Q2 24 | — | 0.85× | ||
| Q1 24 | — | 0.96× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $64.1M |
| Free Cash FlowOCF − Capex | — | $60.9M |
| FCF MarginFCF / Revenue | — | 15.4% |
| Capex IntensityCapex / Revenue | — | 0.8% |
| Cash ConversionOCF / Net Profit | 3.39× | 9.81× |
| TTM Free Cash FlowTrailing 4 quarters | — | $185.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $64.1M | ||
| Q3 25 | $137.3M | $57.9M | ||
| Q2 25 | $137.2M | $42.0M | ||
| Q1 25 | $-117.5M | $34.8M | ||
| Q4 24 | $133.0M | $43.7M | ||
| Q3 24 | $91.8M | $34.4M | ||
| Q2 24 | $107.0M | $31.1M | ||
| Q1 24 | $-125.2M | $24.7M |
| Q4 25 | — | $60.9M | ||
| Q3 25 | — | $52.4M | ||
| Q2 25 | — | $39.7M | ||
| Q1 25 | — | $32.1M | ||
| Q4 24 | — | $35.4M | ||
| Q3 24 | — | $29.5M | ||
| Q2 24 | — | $24.4M | ||
| Q1 24 | — | $18.9M |
| Q4 25 | — | 15.4% | ||
| Q3 25 | — | 15.6% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 12.1% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | — | 11.0% | ||
| Q2 24 | — | 10.7% | ||
| Q1 24 | — | 9.7% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | 3.39× | 9.81× | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | 2.87× | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
ZETA
Segment breakdown not available.
